SCHEMBL8844397

SCHEMBL8844397

CCOC(=O)C(=CC(=O)O)CCBr

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.41
HCAR2 Q8TDS4 1/20 0.38
ALDH1A1 P00352 6/20 0.38
TRPA1 O75762 1/20 0.38
GLO1 Q04760 1/20 0.37
CYP2D6 P10635 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
EGLN1 Q9GZT9 1/20 0.35
LMNA P02545 3/20 0.33
MAPT P10636 2/20 0.33
FAAH O00519 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2C9 P11712 2/20 0.33
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33
MAPK1 P28482 1/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14814142 0.85 ALDH1A1 (0.45) NPSR1HCAR2ALDH1A1TRPA1GLO1
SCHEMBL9471296 0.83 NPSR1 (0.42) NPSR1HCAR2ALDH1A1GLO1CYP2D6
SCHEMBL9628973 0.83 NPSR1 (0.42) NPSR1HCAR2ALDH1A1GLO1CYP2D6
SCHEMBL11398954 0.83 NPSR1 (0.42) NPSR1HCAR2ALDH1A1GLO1CYP2D6
SCHEMBL4795564 0.81 FAAH (0.44) NPSR1HCAR2ALDH1A1GLO1CYP2D6
SCHEMBL7772532 0.80 NPSR1 (0.47) NPSR1HCAR2ALDH1A1GLO1CYP2D6
SCHEMBL7774727 0.80 NPSR1 (0.47) NPSR1HCAR2ALDH1A1GLO1CYP2D6
SCHEMBL703761 0.80 NPSR1 (0.47) NPSR1HCAR2ALDH1A1GLO1CYP2D6
SCHEMBL27619470 0.80 FAAH (0.50) NPSR1ALDH1A1MEN1KMT2AFAAH
SCHEMBL27645522 0.79 ALDH1A1 (0.39) NPSR1ALDH1A1TRPA1GLO1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5627170-A Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contains same and a method of treating calcium metabolism disturbance BOEHRINGER MANNHEIM GMBH (DE) 1997-05-06 US disclosed
US-5538957-A OSTEOPOROSIS BOEHRINGER MANNHEIM GMBH (DE) 1996-07-23 US disclosed